NeuroSystec Corporation Report issue

For profit Phase 1
Founded: Valencia CA United States (2004)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2009
NCT00957788
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

nst-001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tinnitus (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1